Jennison Associates’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-402,609
Closed -$3.28M 640
2016
Q2
$3.28M Sell
402,609
-358
-0.1% -$2.92K ﹤0.01% 506
2016
Q1
$3.28M Sell
402,967
-83,981
-17% -$683K ﹤0.01% 501
2015
Q4
$5.87M Buy
486,948
+1,547
+0.3% +$18.7K 0.01% 503
2015
Q3
$5.81M Buy
485,401
+135,401
+39% +$1.62M 0.01% 523
2015
Q2
$6.42M Buy
+350,000
New +$6.42M 0.01% 520